{"entity":{"type":"insider","cik":"0001365619","url":"/insider/0001365619","json_url":"/insider/0001365619.json","name":"Brege Laura","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":65,"n_filings":41,"first":"2007-08-14","last":"2025-09-12","span_basis":"filed_date"},"name_variants":[{"name":"Brege Laura","source":"filing","n_filings":41,"first_seen":"2007-08-14","last_seen":"2025-09-12"}],"transactions":[{"id":4502124,"accession":"0001415889-25-024463","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-024463","line_url":"/filing/0001415889-25-024463","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":74.40402529411764,"price_display":"74.40","price_state":"stated","total_value":1264868.43,"total_display":"1,264,868.43","total_whole":"1,264,868","shares_owned_after":17194.0,"shares_owned_after_display":"17,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-12","scope":"insider","n_lines":2},{"id":4558337,"accession":"0001415889-25-015832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015832","line_url":"/filing/0001415889-25-015832#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14446.0,"shares_display":"14,446","price_per_share":21.78,"price_display":"21.78","price_state":"stated","total_value":314633.88,"total_display":"314,633.88","total_whole":"314,634","shares_owned_after":15095.0,"shares_owned_after_display":"15,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-05","scope":"insider"},{"id":2188108,"accession":"0001396814-24-000117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001396814-24-000117","line_url":"/filing/0001396814-24-000117#line-1","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.81,"price_display":"12.81","price_state":"stated","total_value":12810.0,"total_display":"12,810.00","total_whole":"12,810","shares_owned_after":17552.0,"shares_owned_after_display":"17,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-19","scope":"insider"},{"id":8043099,"accession":"0001209191-23-037106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037106","line_url":"/filing/0001209191-23-037106#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":24.868,"price_display":"24.87","price_state":"stated","total_value":111906.0,"total_display":"111,906.00","total_whole":"111,906","shares_owned_after":13502.0,"shares_owned_after_display":"13,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":8188353,"accession":"0001209191-23-035254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035254","line_url":"/filing/0001209191-23-035254#line-1","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":38.74,"price_display":"38.74","price_state":"stated","total_value":23244.0,"total_display":"23,244.00","total_whole":"23,244","shares_owned_after":9547.0,"shares_owned_after_display":"9,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":7869302,"accession":"0001209191-23-023336","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023336","line_url":"/filing/0001209191-23-023336#line-2","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":40.72,"price_display":"40.72","price_state":"stated","total_value":285040.0,"total_display":"285,040.00","total_whole":"285,040","shares_owned_after":10147.0,"shares_owned_after_display":"10,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8627022,"accession":"0001209191-23-003554","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003554","line_url":"/filing/0001209191-23-003554#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":228125.0,"total_display":"228,125.00","total_whole":"228,125","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-17","scope":"insider"},{"id":2192932,"accession":"0001209191-20-058830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-058830","line_url":"/filing/0001209191-20-058830#line-2","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":65.95,"price_display":"65.95","price_state":"stated","total_value":791400.0,"total_display":"791,400.00","total_whole":"791,400","shares_owned_after":7921.0,"shares_owned_after_display":"7,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":2287024,"accession":"0001209191-20-035169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-035169","line_url":"/filing/0001209191-20-035169#line-1","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":48.7,"price_display":"48.70","price_state":"stated","total_value":102270.0,"total_display":"102,270.00","total_whole":"102,270","shares_owned_after":6661.0,"shares_owned_after_display":"6,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-08","scope":"insider"},{"id":2282961,"accession":"0001209191-20-002595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-002595","line_url":"/filing/0001209191-20-002595#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.19,"price_display":"42.19","price_state":"stated","total_value":421900.0,"total_display":"421,900.00","total_whole":"421,900","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-08","scope":"insider"},{"id":8728395,"accession":"0001209191-19-049309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049309","line_url":"/filing/0001209191-19-049309#line-1","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":11.22,"price_display":"11.22","price_state":"stated","total_value":112200.0,"total_display":"112,200.00","total_whole":"112,200","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-12","scope":"insider"},{"id":8752721,"accession":"0001209191-19-003427","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003427","line_url":"/filing/0001209191-19-003427#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0041,"price_display":"20.00","price_state":"stated","total_value":200041.0,"total_display":"200,041.00","total_whole":"200,041","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-09","filed_date":"2019-01-11","scope":"insider"},{"id":6313321,"accession":"0001415889-18-000013","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-18-000013","line_url":"/filing/0001415889-18-000013#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0617,"price_display":"30.06","price_state":"stated","total_value":751542.5,"total_display":"751,542.50","total_whole":"751,543","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":3127906,"accession":"0001209191-16-126650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-126650","line_url":"/filing/0001209191-16-126650#line-1","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":46.95,"price_display":"46.95","price_state":"stated","total_value":46950.0,"total_display":"46,950.00","total_whole":"46,950","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":8890837,"accession":"0001415889-15-000537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-15-000537","line_url":"/filing/0001415889-15-000537#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.6349,"price_display":"33.63","price_state":"stated","total_value":336349.0,"total_display":"336,349.00","total_whole":"336,349","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-13","scope":"insider"},{"id":7020271,"accession":"0001415889-14-002815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-14-002815","line_url":"/filing/0001415889-14-002815#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.0669,"price_display":"28.07","price_state":"stated","total_value":280669.0,"total_display":"280,669.00","total_whole":"280,669","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-16","scope":"insider"},{"id":6336146,"accession":"0001181431-14-018953","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-018953","line_url":"/filing/0001181431-14-018953","is_derivative":false,"issuer_cik":"0001365619","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001365619","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":73.845,"price_display":"73.84","price_state":"stated","total_value":738450.0,"total_display":"738,450.00","total_whole":"738,450","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-09","filed_date":"2014-05-09","scope":"insider","n_lines":2},{"id":6623026,"accession":"0001415889-14-001114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-14-001114","line_url":"/filing/0001415889-14-001114#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14285.0,"shares_display":"14,285","price_per_share":22.5359,"price_display":"22.54","price_state":"stated","total_value":321925.3315,"total_display":"321,925.33","total_whole":"321,925","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-04","filed_date":"2014-04-04","scope":"insider"},{"id":7039225,"accession":"0001415889-14-000168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-14-000168","line_url":"/filing/0001415889-14-000168#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.1764,"price_display":"24.18","price_state":"stated","total_value":241764.0,"total_display":"241,764.00","total_whole":"241,764","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-17","scope":"insider"},{"id":4348739,"accession":"0001415889-13-002565","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-13-002565","line_url":"/filing/0001415889-13-002565#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44117.0,"shares_display":"44,117","price_per_share":23.413,"price_display":"23.41","price_state":"stated","total_value":1032911.321,"total_display":"1,032,911.32","total_whole":"1,032,911","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-10","filed_date":"2013-12-12","scope":"insider"},{"id":5031841,"accession":"0001415889-13-002028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-13-002028","line_url":"/filing/0001415889-13-002028#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.6256,"price_display":"21.63","price_state":"stated","total_value":216256.0,"total_display":"216,256.00","total_whole":"216,256","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-10","filed_date":"2013-10-11","scope":"insider"},{"id":4555315,"accession":"0001415889-13-001811","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-13-001811","line_url":"/filing/0001415889-13-001811#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46153.0,"shares_display":"46,153","price_per_share":22.7969,"price_display":"22.80","price_state":"stated","total_value":1052145.3257,"total_display":"1,052,145.33","total_whole":"1,052,145","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-10","filed_date":"2013-09-12","scope":"insider"},{"id":8929256,"accession":"0001209191-11-051862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-051862","line_url":"/filing/0001209191-11-051862#line-3","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":36.01,"price_display":"36.01","price_state":"stated","total_value":360100.0,"total_display":"360,100.00","total_whole":"360,100","shares_owned_after":39670.0,"shares_owned_after_display":"39,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-14","filed_date":"2011-10-17","scope":"insider"},{"id":9114571,"accession":"0001209191-11-039578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-039578","line_url":"/filing/0001209191-11-039578#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":39427.0,"shares_owned_after_display":"39,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-14","filed_date":"2011-07-14","scope":"insider"},{"id":9174410,"accession":"0001209191-11-024688","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-024688","line_url":"/filing/0001209191-11-024688","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.002,"price_display":"35.00","price_state":"stated","total_value":350020.0,"total_display":"350,020.00","total_whole":"350,020","shares_owned_after":41427.0,"shares_owned_after_display":"41,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-26","filed_date":"2011-04-27","scope":"insider","n_lines":2},{"id":8868855,"accession":"0001209191-11-021295","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-021295","line_url":"/filing/0001209191-11-021295#line-3","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":35.02,"price_display":"35.02","price_state":"stated","total_value":245140.0,"total_display":"245,140.00","total_whole":"245,140","shares_owned_after":39427.0,"shares_owned_after_display":"39,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-01","filed_date":"2011-04-04","scope":"insider"},{"id":9062251,"accession":"0001209191-11-004090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-004090","line_url":"/filing/0001209191-11-004090#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":35.6383,"price_display":"35.64","price_state":"stated","total_value":445478.75,"total_display":"445,478.75","total_whole":"445,479","shares_owned_after":18927.0,"shares_owned_after_display":"18,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-18","filed_date":"2011-01-20","scope":"insider"},{"id":7733412,"accession":"0001209191-10-054143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-054143","line_url":"/filing/0001209191-10-054143#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":18514.0,"shares_owned_after_display":"18,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-08","filed_date":"2010-11-10","scope":"insider"},{"id":7547383,"accession":"0001209191-10-022894","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-022894","line_url":"/filing/0001209191-10-022894","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":30.39568,"price_display":"30.40","price_state":"stated","total_value":379946.0,"total_display":"379,946.00","total_whole":"379,946","shares_owned_after":19026.0,"shares_owned_after_display":"19,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-15","filed_date":"2010-04-19","scope":"insider","n_lines":2},{"id":7414263,"accession":"0001209191-10-020349","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-020349","line_url":"/filing/0001209191-10-020349#line-3","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4334.0,"shares_display":"4,334","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":130453.4,"total_display":"130,453.40","total_whole":"130,453","shares_owned_after":18126.0,"shares_owned_after_display":"18,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-01","filed_date":"2010-04-02","scope":"insider"},{"id":7414260,"accession":"0001209191-10-020349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-020349","line_url":"/filing/0001209191-10-020349#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":30.15,"price_display":"30.15","price_state":"stated","total_value":100489.95,"total_display":"100,489.95","total_whole":"100,490","shares_owned_after":22460.0,"shares_owned_after_display":"22,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-31","filed_date":"2010-04-02","scope":"insider"},{"id":7287997,"accession":"0001209191-10-004002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-004002","line_url":"/filing/0001209191-10-004002#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":30.12,"price_display":"30.12","price_state":"stated","total_value":376500.0,"total_display":"376,500.00","total_whole":"376,500","shares_owned_after":17793.0,"shares_owned_after_display":"17,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-15","filed_date":"2010-01-20","scope":"insider"},{"id":5711900,"accession":"0001209191-09-055480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-055480","line_url":"/filing/0001209191-09-055480#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","total_whole":"375,000","shares_owned_after":17516.0,"shares_owned_after_display":"17,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-02","filed_date":"2009-12-04","scope":"insider"},{"id":6087804,"accession":"0001209191-09-037644","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-037644","line_url":"/filing/0001209191-09-037644#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":35.9,"price_display":"35.90","price_state":"stated","total_value":897500.0,"total_display":"897,500.00","total_whole":"897,500","shares_owned_after":17516.0,"shares_owned_after_display":"17,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-22","filed_date":"2009-07-24","scope":"insider"},{"id":5727716,"accession":"0001209191-09-020054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-020054","line_url":"/filing/0001209191-09-020054#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5333.0,"shares_display":"5,333","price_per_share":27.9,"price_display":"27.90","price_state":"stated","total_value":148790.7,"total_display":"148,790.70","total_whole":"148,791","shares_owned_after":17241.0,"shares_owned_after_display":"17,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-01","filed_date":"2009-04-02","scope":"insider"},{"id":5596680,"accession":"0001209191-09-003874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-003874","line_url":"/filing/0001209191-09-003874#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":32.81,"price_display":"32.81","price_state":"stated","total_value":410125.0,"total_display":"410,125.00","total_whole":"410,125","shares_owned_after":15574.0,"shares_owned_after_display":"15,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-15","filed_date":"2009-01-20","scope":"insider"},{"id":4158363,"accession":"0001209191-08-059891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-059891","line_url":"/filing/0001209191-08-059891#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","total_whole":"375,000","shares_owned_after":15430.0,"shares_owned_after_display":"15,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-07","filed_date":"2008-11-10","scope":"insider"},{"id":3858861,"accession":"0001209191-08-042867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-042867","line_url":"/filing/0001209191-08-042867#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":37.5,"price_display":"37.50","price_state":"stated","total_value":468750.0,"total_display":"468,750.00","total_whole":"468,750","shares_owned_after":15430.0,"shares_owned_after_display":"15,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-15","filed_date":"2008-07-17","scope":"insider"},{"id":3801441,"accession":"0001209191-08-024396","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-024396","line_url":"/filing/0001209191-08-024396#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":415250.0,"total_display":"415,250.00","total_whole":"415,250","shares_owned_after":15079.0,"shares_owned_after_display":"15,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-15","filed_date":"2008-04-16","scope":"insider"},{"id":3628052,"accession":"0001209191-08-022023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-022023","line_url":"/filing/0001209191-08-022023#line-3","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2142.0,"shares_display":"2,142","price_per_share":30.87,"price_display":"30.87","price_state":"stated","total_value":66123.54,"total_display":"66,123.54","total_whole":"66,124","shares_owned_after":15079.0,"shares_owned_after_display":"15,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-02","filed_date":"2008-04-02","scope":"insider"},{"id":3705190,"accession":"0001209191-08-003979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-003979","line_url":"/filing/0001209191-08-003979#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":50.89,"price_display":"50.89","price_state":"stated","total_value":636125.0,"total_display":"636,125.00","total_whole":"636,125","shares_owned_after":12413.0,"shares_owned_after_display":"12,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-15","filed_date":"2008-01-16","scope":"insider"},{"id":7024166,"accession":"0001209191-07-047967","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-07-047967","line_url":"/filing/0001209191-07-047967#line-21","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19608.0,"shares_display":"19,608","price_per_share":31.25,"price_display":"31.25","price_state":"stated","total_value":612750.0,"total_display":"612,750.00","total_whole":"612,750","shares_owned_after":11512.0,"shares_owned_after_display":"11,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-10","filed_date":"2007-08-14","scope":"insider"},{"id":7024165,"accession":"0001209191-07-047967","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-07-047967","line_url":"/filing/0001209191-07-047967#line-20","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11092.0,"shares_display":"11,092","price_per_share":31.5,"price_display":"31.50","price_state":"stated","total_value":349398.0,"total_display":"349,398.00","total_whole":"349,398","shares_owned_after":42220.0,"shares_owned_after_display":"42,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-10","filed_date":"2007-08-14","scope":"insider"},{"id":7024163,"accession":"0001209191-07-047967","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-07-047967","line_url":"/filing/0001209191-07-047967#line-19","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":31.61,"price_display":"31.61","price_state":"stated","total_value":116957.0,"total_display":"116,957.00","total_whole":"116,957","shares_owned_after":56812.0,"shares_owned_after_display":"56,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-10","filed_date":"2007-08-14","scope":"insider"},{"id":7024161,"accession":"0001209191-07-047967","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-07-047967","line_url":"/filing/0001209191-07-047967#line-18","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":31.4,"price_display":"31.40","price_state":"stated","total_value":109900.0,"total_display":"109,900.00","total_whole":"109,900","shares_owned_after":38220.0,"shares_owned_after_display":"38,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-10","filed_date":"2007-08-14","scope":"insider"},{"id":7024159,"accession":"0001209191-07-047967","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-07-047967","line_url":"/filing/0001209191-07-047967#line-17","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001365619","owner_name":"Brege Laura","owner_display_name":"Brege Laura","owner_url":"/insider/0001365619","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":31.53,"price_display":"31.53","price_state":"stated","total_value":81978.0,"total_display":"81,978.00","total_whole":"81,978","shares_owned_after":53312.0,"shares_owned_after_display":"53,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-10","filed_date":"2007-08-14","scope":"insider"}],"collapsed":true,"next_cursor":"2007-08-10|7024159","ledger_fault":false,"count":{"value":65,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":63,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":65},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Director","n_filings":2,"first_seen":"2019-09-12","last_seen":"2025-09-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Director","n_filings":13,"first_seen":"2013-09-12","last_seen":"2025-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira BioSciences, Inc.","url":"/issuer/0001396814","role":"Director","n_filings":7,"first_seen":"2014-05-09","last_seen":"2024-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001012140","name":"ONYX PHARMACEUTICALS INC","url":"/issuer/0001012140","role":"Officer (EVP, Corporate Affairs)","n_filings":19,"first_seen":"2007-08-14","last_seen":"2011-10-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001365619","retrieved_at":"2026-08-26T10:10:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}